Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
Andrew Schaefer,1 Ying Huang,2 Adam Kittai,2 Joseph E Maakaron,3 Caner Saygin,4 Jonathan Brammer,2 Sam Penza,2 Ayman Saad,2 Samantha M Jaglowski,2 Basem M William5 1Department of Medicine, University of Wisconsin, Madison, WI, USA; 2Department of Internal Medicine, The Ohio State University, Columbu...
Guardado en:
Autores principales: | Schaefer A, Huang Y, Kittai A, Maakaron JE, Saygin C, Brammer J, Penza S, Saad A, Jaglowski SM, William BM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/058e8dcd42a74747943e4a3367543dde |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Follicular lymphoma
por: Lali G. Babicheva, et al.
Publicado: (2020) -
Excess Mortality by Multimorbidity, Socioeconomic, and Healthcare Factors, amongst Patients Diagnosed with Diffuse Large B-Cell or Follicular Lymphoma in England
por: Matthew James Smith, et al.
Publicado: (2021) -
Comparación entre CHOP-like y R-CHOP en pacientes con linfoma no Hodgkin difuso de grandes células B y folicular: 10 años de experiencia del Hospital de Clínicas de Montevideo, Uruguay
por: Oliver,Carolina, et al.
Publicado: (2013) -
Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers
por: Yasuhito Mihashi, et al.
Publicado: (2021) -
Impact of obinutuzumab alone and in combination for follicular lymphoma
por: Sarraf Yazdy M, et al.
Publicado: (2017)